Abstract
To successfully meet new challenges, policy-makers may have to bridge between different stakeholders, countries, segments, products and types of health care. Issues regarding policy cooperation and interface management in this field may be related to bridging out-patient and in-patient sectors, medicines and medical devices (treatment packages), pharmaceutical pricing and reimbursement, international cooperation initiatives (e.g. joint procurement), international databases (e.g. price/utilization databases) and international comparisons and benchmarking (e.g. cross-country price/utilization comparisons).
Highlights
To successfully meet new challenges, policy-makers may have to bridge between different stakeholders, countries, segments, products and types of health care
The urgent need to improve this type of interface management has been identified in the European Commission’s co-funded project ‘Pharmaceutical Health Information System’ (PHIS) running from 2008 until 2011 [2]. It has been followed up in the 2nd Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference held in Vienna on 29 and 30 September 2011, with a special strand devoted to it
In the Stockholm healthcare region in Sweden, a list of essential medicines recommendations valid for the out-patient and in-patient sectors is annually decided by a Joint Drugs and Therapeutics Committee (DTC) [7]
Summary
To successfully meet new challenges, policy-makers may have to bridge between different stakeholders, countries, segments, products and types of health care. It has been followed up in the 2nd Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference held in Vienna on 29 and 30 September 2011, with a special strand devoted to it.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
